Crossmark

Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH)

Published Online: 2022-10-24

Published Print: 2022-12-07

Authors

Weißert, Kristoffer https://orcid.org/0000-0002-9850-6039
Ammann, Sandra https://orcid.org/0000-0003-0385-1890
Kögl, Tamara

Dettmer‐Monaco, Viviane

Schell, Christoph

Cathomen, Toni https://orcid.org/0000-0002-7757-4630
Ehl, Stephan https://orcid.org/0000-0002-9265-2721
Aichele, Peter https://orcid.org/0000-0002-0891-9877
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (CRC1160 (A07, B04, Z01))
License Information

Version of Record valid from 2022-10-24
More Information

Publication History

Received: 2022-04-05

Accepted: 2022-09-29

Published: 2022-10-24

Document is current